Published in Transfusion on December 01, 2007
Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev (2011) 1.47
The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions. Transfusion (2013) 1.43
Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™ Transfus Med Hemother (2011) 1.04
Pathogen inactivation technologies for cellular blood components: an update. Transfus Med Hemother (2014) 0.90
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates. Transfus Med Hemother (2011) 0.83
Current methods for the reduction of blood-borne pathogens: a comprehensive literature review. Blood Transfus (2013) 0.83
Laboratory Evaluation of the Effectiveness of Pathogen Reduction Procedures for Bacteria. Transfus Med Hemother (2011) 0.81
Effects of pathogen reduction systems on platelet microRNAs, mRNAs, activation, and function. Platelets (2014) 0.81
Pathogen inactivation: a new paradigm for blood safety. Transfusion (2007) 0.75
Septic shock during platelet transfusion in a patient with acute myeloid leukaemia. BMJ Case Rep (2013) 0.75
The consensus development process in transfusion medicine: does it add value? Transfusion (2007) 0.75
Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use. Blood Transfus (2016) 0.75
ALLOGENEIC PLATELET-RICH PLASMA FOR ROTATOR CUFF REPAIR. Acta Ortop Bras (2017) 0.75
Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone. CMAJ (2009) 9.83
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology (2007) 9.44
A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med (2003) 6.57
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Ann Intern Med (2009) 5.48
High risk clinical characteristics for subarachnoid haemorrhage in patients with acute headache: prospective cohort study. BMJ (2010) 4.65
Clinical decision rules to rule out subarachnoid hemorrhage for acute headache. JAMA (2013) 4.34
Cost effectiveness of EML4-ALK fusion testing and first-line crizotinib treatment for patients with advanced ALK-positive non-small-cell lung cancer. J Clin Oncol (2014) 4.31
Comparison of the 20-hour intravenous and 72-hour oral acetylcysteine protocols for the treatment of acute acetaminophen poisoning. Ann Emerg Med (2009) 3.67
External validation of the paracetamol-aminotransferase multiplication product to predict hepatotoxicity from paracetamol overdose. Clin Toxicol (Phila) (2015) 3.24
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies. Ann Intern Med (2012) 3.05
Prospective validation of the ABCD2 score for patients in the emergency department with transient ischemic attack. CMAJ (2011) 2.45
Hepatitis B virus genotypes in the United States: results of a nationwide study. Gastroenterology (2003) 2.38
Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B. Liver Transpl (2002) 2.25
Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells (2006) 2.20
End-of-life care for lung cancer patients in the United States and Ontario. J Natl Cancer Inst (2011) 2.14
Integrating Physician Services in the Home: evaluation of an innovative program. Can Fam Physician (2010) 2.13
Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity (2013) 2.08
Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses. J Virol (2007) 2.05
A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events. N Engl J Med (2015) 2.03
A prospective cohort study of patients with transient ischemic attack to identify high-risk clinical characteristics. Stroke (2013) 2.03
Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2007) 2.01
Iron stores and vascular function in voluntary blood donors. Arterioscler Thromb Vasc Biol (2005) 1.94
Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol (2003) 1.84
Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care. Ann Emerg Med (2009) 1.74
Utilization of and adherence to the gastroenterology core curriculum on hepatology training during a gastrointestinal fellowship. Clin Gastroenterol Hepatol (2008) 1.72
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques. Nat Med (2010) 1.71
Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. Clin Infect Dis (2006) 1.69
The strong ion gap predicts mortality in children following cardiopulmonary bypass surgery. Pediatr Crit Care Med (2005) 1.68
Comparative operative outcomes of early and delayed cholecystectomy for acute cholecystitis: a population-based propensity score analysis. Ann Surg (2014) 1.65
Health care costs associated with hepatocellular carcinoma: a population-based study. Hepatology (2013) 1.63
Should spectrophotometry be used to identify xanthochromia in the cerebrospinal fluid of alert patients suspected of having subarachnoid hemorrhage? Stroke (2006) 1.61
Canadian Helicobacter Study Group Consensus Conference: Update on the management of Helicobacter pylori--an evidence-based evaluation of six topics relevant to clinical outcomes in patients evaluated for H pylori infection. Can J Gastroenterol (2004) 1.59
Does cryosupernatant plasma improve outcome in thrombotic thrombocytopenic purpura? No answer yet. Br J Haematol (2005) 1.57
Subdissociative-dose ketamine versus fentanyl for analgesia during propofol procedural sedation: a randomized clinical trial. Acad Emerg Med (2008) 1.57
Mid-term outcomes following endovascular re-intervention for iliac artery in-stent restenosis. Catheter Cardiovasc Interv (2013) 1.56
Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: a proof of concept study in HIV-2287-infected macaques. J Acquir Immune Defic Syndr (2003) 1.55
The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg (2009) 1.52
Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: a retrospective cohort study. Clin Toxicol (Phila) (2012) 1.52
Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin. J Clin Oncol (2002) 1.52
Heterotrimeric G protein gamma subunits provide functional selectivity in Gbetagamma dimer signaling in Arabidopsis. Plant Cell (2007) 1.51
Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care (2005) 1.50
"Early" delayed sternal closure following pediatric cardiac surgery. Ann Thorac Surg (2005) 1.50
Prevalence of HBV precore/core promoter variants in the United States. Hepatology (2003) 1.47
Respiratory Dysfunction Associated With RBC Transfusion in Critically Ill Children: A Prospective Cohort Study. Pediatr Crit Care Med (2015) 1.46
Exposure to concentrated ambient particles does not affect vascular function in patients with coronary heart disease. Environ Health Perspect (2008) 1.45
Validation of the Kenz Lifecorder EX and ActiGraph GT1M accelerometers for walking and running in adults. Appl Physiol Nutr Metab (2008) 1.45
Potential impact of N-terminal pro-BNP testing on the emergency department evaluation of acute dyspnea. CJEM (2006) 1.44
Outcomes following the Kawashima procedure for single-ventricle palliation in left atrial isomerism. Eur J Cardiothorac Surg (2011) 1.43
Sapien 3 Transcatheter Aortic Valve Implantation With Moderate or Without Predilation. J Invasive Cardiol (2016) 1.43
The cost-effectiveness of extended-duration antithrombotic prophylaxis after total hip arthroplasty. J Bone Joint Surg Am (2007) 1.42
Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention. Catheter Cardiovasc Interv (2013) 1.42
Liaison psychiatry for older people--an overlooked opportunity. Age Ageing (2005) 1.42
Self-expanding stent implantation in arterial duct during hybrid palliation of hypoplastic left heart syndrome: midterm experience with a specially designed stent. EuroIntervention (2015) 1.39
Regression methods for covariate adjustment and subgroup analysis for non-censored cost-effectiveness data. Health Econ (2004) 1.37
The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline. Transfus Med Rev (2010) 1.37
Hospital costs and length of stay among homeless patients admitted to medical, surgical, and psychiatric services. Med Care (2011) 1.33
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood (2004) 1.31
Triple nucleoside treatment with abacavir plus the lamivudine/zidovudine combination tablet (COM) compared to indinavir/COM in antiretroviral therapy-naïve adults: results of a 48-week open-label, equivalence trial (CNA3014). Curr Med Res Opin (2004) 1.30
Optimization of lipid-indinavir complexes for localization in lymphoid tissues of HIV-infected macaques. J Acquir Immune Defic Syndr (2006) 1.29
Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin: an assessment of safety and pharmacodynamics: the DIRECT study. Arch Intern Med (2008) 1.28
Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol Bioeng (2009) 1.28
Outbreaks of infection caused by community-acquired methicillin-resistant Staphylococcus aureus in a Canadian correctional facility. Can J Infect Dis Med Microbiol (2005) 1.27
Re-utilization outcomes and costs of minor acute illness treated at family physician offices, walk-in clinics, and emergency departments. Can Fam Physician (2005) 1.25
Evaluation of HIV and highly active antiretroviral therapy on the natural history of human papillomavirus infection and cervical cytopathologic findings in HIV-positive and high-risk HIV-negative women. J Infect Dis (2013) 1.25
Compliance with practice guidelines and risk of a first esophageal variceal hemorrhage in patients with cirrhosis. Clin Gastroenterol Hepatol (2010) 1.23
A pilot randomized trial of adjuvant rituximab or placebo for nonsplenectomized patients with immune thrombocytopenia. Blood (2012) 1.22
Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial. CMAJ (2005) 1.22
Guideline for the management of late-life depression in primary care. Int J Geriatr Psychiatry (2003) 1.22
Prescription drug benefits and Canada's uninsured. Int J Law Psychiatry (2005) 1.21
Improving chronic disease prevention and screening in primary care: results of the BETTER pragmatic cluster randomized controlled trial. BMC Fam Pract (2013) 1.17
Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Am J Med Genet C Semin Med Genet (2005) 1.16
Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera. Clin Vaccine Immunol (2008) 1.15
Evidence for persistent, occult infection in neonatal macaques following perinatal transmission of simian-human immunodeficiency virus SF162P3. J Virol (2006) 1.15
Real time monitoring of risk-adjusted paediatric cardiac surgery outcomes using variable life-adjusted display: implementation in three UK centres. Heart (2013) 1.15
Osteoporosis disease management: What every orthopaedic surgeon should know. J Bone Joint Surg Am (2009) 1.14
Hidden specificity in an apparently nonspecific RNA-binding protein. Nature (2013) 1.13
A randomized controlled trial of HIV therapeutic vaccination using ALVAC with or without Remune. AIDS (2011) 1.10
Complications of apheresis in children. Transfusion (2007) 1.10
Pragmatic interpretation of the study of nontraumatic subarachnoid hemorrhage in the setting of negative cranial computed tomography results: external validation of a clinical and imaging prediction rule. Ann Emerg Med (2013) 1.08
Development of a whole-virus multiplex flow cytometric assay for antibody screening of a specific pathogen-free primate colony. Diagn Microbiol Infect Dis (2005) 1.08
Factors affecting outcome following transplantation of ex vivo expanded limbal epithelium on amniotic membrane for total limbal deficiency in rabbits. Invest Ophthalmol Vis Sci (2002) 1.08
Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study. AIDS Res Ther (2010) 1.06
Relapse after emergency department discharge for acute asthma. Acad Emerg Med (2008) 1.06
Is ambulatory monitoring for "community-acquired" syncope economically attractive? A cost-effectiveness analysis of a randomized trial of external loop recorders versus Holter monitoring. Am Heart J (2005) 1.05
Access to cancer drugs in Canada: looking beyond coverage decisions. Healthc Policy (2011) 1.05
Placebo practice trials: a tool to assess and improve adherence readiness. HIV Clin Trials (2002) 1.05
Vif substitution enables persistent infection of pig-tailed macaques by human immunodeficiency virus type 1. J Virol (2011) 1.05
Common culture conditions for maintenance and cardiomyocyte differentiation of the human embryonic stem cell lines, BG01 and HUES-7. Int J Dev Biol (2006) 1.04
The evaluation and use of economic evidence to inform cancer drug reimbursement decisions in Canada. Pharmacoeconomics (2013) 1.03
Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index. J Infect Dis (2010) 1.03
Cardiac magnetic resonance imaging after stage I Norwood operation for hypoplastic left heart syndrome. Circulation (2005) 1.02
Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies. Influenza Other Respir Viruses (2013) 1.02
Cost-effectiveness of screening for anal precancers in HIV-positive men. AIDS (2011) 1.02
Consensus conference on vCJD screening of blood donors: report of the panel. Transfusion (2004) 1.02
Pattern of antidepressant use and duration of depression-related absence from work. Br J Psychiatry (2003) 1.01
Differential pathogenicity of SHIV infection in pig-tailed and rhesus macaques. J Med Primatol (2008) 1.00
Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1-Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial. AIDS Res Treat (2012) 1.00